Skip to content
Endosense logo — company profile

Endosense

Founded 2003 Switzerland Meyrin, Switzerland 1 employees Series C Total: $144.00M Biotechnology, Health Care +2

General Information

Company Name Endosense
Founded Year 2003
Location Switzerland Meyrin, Switzerland
Employees 1
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Endosense. To contact Endosense, visit endosense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Endosense compare?

A PDF of Endosense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Endosense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Endosense

Endosense is a Switzerland-based medical technology company that focuses on enhancing the effectiveness, safety, and reproducibility of catheter ablation for treating cardiac arrhythmias. Founded in 2003, the company has developed the TactiCath Quartz®, the pioneering force-sensing ablation catheter that provides real-time, objective feedback on contact force during the procedure. Clinical studies have demonstrated that utilizing contact force during ablation can reduce procedure time and minimize PV gaps at 3-month invasive follow-up. The most recent investment in Endosense was a Fr.37.40M Series C funding round on 27 November 2013. The investors in this round included GIMV, VI Partners, NeoMed Management, Sectoral Asset Management, Ysios Capital, NGN Capital, Andera Partners, and Initiative Capital Romandie. This investment reaffirms the confidence of the investor community in the potential of Endosense and its innovative technology to make significant advancements in the field of cardiac arrhythmia treatment.

Business keywords: catheter ablation, cardiac arrhythmias, clinical studies, contact force, TactiCath Quartz, force-sensing ablation, procedure efficacy, patient safety, reproducibility, heart wall perforation risk, recurrence risk, ablation catheter, real-time measurement, force control

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Fr.37.40M 8
GIMV, VI Partners +6
27 Nov 2013
Series C $4.30M -
06 Mar 2013
Series C $40.30M 2
Initiative Capital, VI Partners
27 Nov 2012
Series B $36.00M -
27 Oct 2009
Series A Fr.26.00M -
21 Nov 2005

Endosense Alternatives & Competitors

Endosense vs
Apama Medical
Apama Medical United States

Apama Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley ba...

Debt Financing
5 employees
Biotechnology, Health Care
Endosense vs

SÉCURITÉ DES PATIENTS ET EFFICIENCE DE LA MÉDICATION La pharmacie clinique augmentée, levier de perf...

Venture round
18 employees
Data Analytics, Health Care

FAQ About Endosense

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The company has conducted numerous clinical studies and has shown that using contact force during ablation can reduce procedure time...
Endosense was founded in 2003.
Endosense is headquartered in Meyrin, Switzerland.
Endosense operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on catheter ablation, cardiac arrhythmias, clinical studies and contact force.
Endosense has approximately 1 employees.
Endosense has completed 5 funding rounds, raising a total of $144.00M. The latest funding stage is Series C.
Top alternatives and competitors to Endosense include Apama Medical, Keenturtle. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Endosense and Apama Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Endosense, https://www.bouncewatch.com/company/endosense, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout